Invention Grant
- Patent Title: Systems and methods for predicting lung cancer immune therapy responsiveness using quantitative textural analysis
-
Application No.: US15237530Application Date: 2016-08-15
-
Publication No.: US11120888B2Publication Date: 2021-09-14
- Inventor: Ronald L. Korn
- Applicant: Imaging Endpoints II LLC
- Applicant Address: US AZ Scottsdale
- Assignee: Imaging Endpoints II LLC
- Current Assignee: Imaging Endpoints II LLC
- Current Assignee Address: US AZ Scottsdale
- Agency: Quarles & Brady LLP
- Main IPC: G16B5/00
- IPC: G16B5/00 ; G16B40/00 ; G16B20/00

Abstract:
Methods and apparatus for predicting responsiveness to immune therapy in lung cancer. The method includes the steps of: identifying a first population of known responders and a second population of known non-responders; processing imaging data for the first and second populations using quantitative textural analysis (QTA); generating, for each member of both populations, quantitative metrics using the QTA; performing logistic regression on the quantitative metrics for both populations to yield a predictive signature expressed in the form of Y=Mx+B where x comprises mean pixel density; performing QTA on a lung cancer scan for a subsequent patient; comparing the predictive signature to one or more relevant metrics associated with the subsequent patient; and predicting responsiveness to immune therapy for the subsequent patient based on the comparison.
Public/Granted literature
Information query